Conference item icon

Conference item

Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease

Abstract:

Importance: Myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) are consistently identified in a range of demyelinating disorders in adults and children. Current therapeutic strategies are largely center specific, and no treatments have been formally evaluated.

Objective: To examine the clinical phenotypes, treatment responses, and outcomes of children with relapsing MOG-Ab-associated disease.

Design, Setting, and Participants:

Expand abstract
Publication status:
Published
Peer review status:
Reviewed (other)

Actions


Access Document


Authors


More by this author
Role:
Author
ORCID:
0000-0002-5464-3779
Expand authors...
Publisher:
American Medical Association Publisher's website
Journal:
JAMA Neurology
Volume:
75
Issue:
4
Pages:
478-487
Host title:
JAMA Neurology
Publication date:
2018-01-05
Acceptance date:
2017-10-19
Event location:
United States
DOI:
EISSN:
2168-6157
ISSN:
2168-6149
Pmid:
29305608
Source identifiers:
813529

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP